Jeffrey M. Spier, MD, Author at Grand Rounds in Urology

Jeffrey M. Spier, MD

Rio Grande Urology

El Paso, Texas

Jeffrey M. Spier, MD, is the president of Rio Grande Urology (RGU) in El Paso, Texas. Dr. Spier earned his medical degree from the University of Texas Medical Branch in Galveston, Texas, where he also completed general surgery and urology residency training.

Dr. Spier has overseen tremendous growth of RGU, which was founded in 2008 and serves West Texas and Southern New Mexico. RGU is the largest private practice physician group in the region, with 23 providers, five offices, and two radiation centers, employing over 250 staff in El Paso, Texas and Las Cruces, New Mexico. Under Dr. Spier’s leadership, RGU continues to expand with the formation of the Rio Grande Cancer Specialists (RGCS), providing radiation therapy, and the RGCS Advanced Prostate Cancer, a center of excellence for clinical research with ongoing expansion into other genitourinary oncologic conditions. RGU is committed to serving the urologic and oncologic needs of patients, providing state of the art and compassionate care.

Dr. Spier is board certified by the American Board of Urology and is a member of the American Urological Association (AUA) and South Central Section of the AUA. He currently serves as an officer for the Large Urology Group Practice Association (LUGPA) in the position of secretary. He has served on multiple committees for LUGPA and is the current chair of the Membership Committee. Dr. Spier is also the president of the El Paso County Medical Society, board member of the University of Texas at Galveston Alumni Board of Trustees, and has served on the board of the Texas Urological Society.

Talks by Jeffrey M. Spier, MD

LUGPA Talk: Healthcare Landscape, Reimbursement

Posted by Jeffrey M. Spier, MD | Nov 2024

Jeffrey M. Spier, MD, focuses on reimbursement, healthcare policy, and the role of advocacy in the current urology healthcare landscape. In this 10-minute presentation, Spier highlights LUGPA, which represents independent urology practices, promoting best practices, business acumen in urology, and policy advocacy.

Spier emphasizes the importance of urologists and healthcare professionals engaging in legislative advocacy to address issues such as reimbursement cuts, regulatory burdens, and rising operational costs. He notes that healthcare consolidation can negatively impact patient care and stresses the need for reform, particularly in areas like the Medicare fee schedule.

Spear advocates for unity within the urology community. He remains optimistic, calling for collective efforts to secure better outcomes for both physicians and patients while urging professionals to engage at local and national levels to make meaningful change.

Update on PROBASE Trial: Baseline PSA in Young Men (Aged 45 and 50)

Posted by Jeffrey M. Spier, MD | Oct 2024

APC Pathways – The Large Urology Group Practice Model

Posted by Jeffrey M. Spier, MD | Aug 2024

Jeffrey M. Spier, MD, and Travis Mendel, MD, discuss the use of Advanced Prostate Cancer (APC) Pathways within large urology group practices. Dr. Spier begins by reviewing the impact of oral options and other advances in treatment collaboration between APC patients and their physicians which led to the formation of large urology group practices.

Dr. Spier then discusses the factors which contribute to the success of large urology groups in treating patients with APC, with an emphasis on improved quality of care. He highlights the importance of combining real-world clinical intelligence with a multidisciplinary approach for continuous improvement in the quality of care received by patients.

Dr. Mendel takes over from Dr. Spier by explaining the differences between clinical guidelines and clinical pathways. He presents examples of treatment pathways for various stages of APC, with a focus on the impact of PSMA-PET.

Dr. Mendel concludes by discussing the potential use of these pathways in creating better AI treatment aids for physicians. Dr. Spier ends the presentation with an emphasis on the positive impact of a multidisciplinary team.